[Insulin autoimmune syndrome].
Hirata
Yukimasa
Y
Tokyo Women's Medical University, Diabetes Center.
D001323:Autoantibodies; D001327:Autoimmune Diseases / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D003937:Diagnosis, Differential; D006680:HLA Antigens; D006801:Humans; D006943:Hyperglycemia; D006946:Hyperinsulinism / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D007003:Hypoglycemia / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D007330:Insulin Antibodies; D008713:Methimazole / Q000009:adverse effects; D013577:Syndrome; D008625:Tiopronin / Q000009:adverse effects
D001323:Autoantibodies; D006680:HLA Antigens; D007330:Insulin Antibodies; D008713:Methimazole; D008625:Tiopronin